These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma. Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593 [TBL] [Abstract][Full Text] [Related]
23. Occult breast cancer presenting with axillary metastasis. Svastics E; Rónay P; Bodó M Eur J Surg Oncol; 1993 Dec; 19(6):575-80. PubMed ID: 8270047 [TBL] [Abstract][Full Text] [Related]
24. [Management of the axilla in breast cancer: evidences and unresolved issues]. Fodor J; Polgár C; Péley G; Németh G Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099 [TBL] [Abstract][Full Text] [Related]
25. Primary carcinoma of the breast without axillary lymph node metastases. Fracchia AA; Rosen PP; Ashikari R Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307 [No Abstract] [Full Text] [Related]
26. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Veronesi U; Luini A; Galimberti V; Marchini S; Sacchini V; Rilke F Eur J Surg Oncol; 1990 Apr; 16(2):127-33. PubMed ID: 2323409 [TBL] [Abstract][Full Text] [Related]
27. Axillary staging in women with small invasive breast tumours. della Rovere GQ; Bonomi R; Ashley S; Benson JR Eur J Surg Oncol; 2006 Sep; 32(7):733-7. PubMed ID: 16814511 [TBL] [Abstract][Full Text] [Related]
28. Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL (A-ROLL). Aydogan F; Ozben V; Atasoy D; Yilmaz MH; Halaç M; Celik V J Surg Oncol; 2010 Feb; 101(2):141-4. PubMed ID: 19937993 [TBL] [Abstract][Full Text] [Related]
29. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
30. Axillary lymph nodes as occult site of breast cancer. Heide RK Va Med; 1978 Mar; 105(3):193-4, 219-20. PubMed ID: 636544 [TBL] [Abstract][Full Text] [Related]
31. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A Breast J; 2006; 12(4):294-301. PubMed ID: 16848838 [TBL] [Abstract][Full Text] [Related]
32. [Identification of the sentinel node in patients with breast carcinoma]. Nieweg OE; Kapteijn BA; Peterse JL; Rutgers EJ; van Dongen JA; Kroon BB Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2235-9. PubMed ID: 8984369 [TBL] [Abstract][Full Text] [Related]
33. 'Occult' breast cancer. Lloyd MS; Nash AG Ann R Coll Surg Engl; 2001 Nov; 83(6):420-4. PubMed ID: 11777139 [TBL] [Abstract][Full Text] [Related]
34. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. Colpaert C; Vermeulen P; Jeuris W; van Beest P; Goovaerts G; Weyler J; Van Dam P; Dirix L; Van Marck E J Pathol; 2001 Apr; 193(4):442-9. PubMed ID: 11276002 [TBL] [Abstract][Full Text] [Related]
35. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Yu J; Li G; Li J; Wang Y Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269 [TBL] [Abstract][Full Text] [Related]
36. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L; J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260 [TBL] [Abstract][Full Text] [Related]
37. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
38. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525 [TBL] [Abstract][Full Text] [Related]
39. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
40. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Harris EE; Hwang WT; Seyednejad F; Solin LJ Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]